Nucleic acid molecules containing recombination sites and methods of using the same

• US 9,534,252 B2
• Filed: 09/14/2012
• Issued: 01/03/2017
• Est. Priority Date: 12/01/2003
• Status: Active Grant

• Current Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Original Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Inventors: Chesnut, Jonathan, Leong, Louis
• Primary Examiner(s): Marvich, Maria
• Application Number:
  US13/619,194
• Publication Number:
  US 20130316350A1
• Time in Patent Office: 1,572 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: C12P 19/34 Polynucleotides, e.g. nucleic acids, oligoribonucleotides
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2521/507 Recombinase
• CPC Class Codes: C12Q 2535/101 Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides as chain terminators
• CPC Class Codes: C12Q 2535/125 Allele specific primer extension

Abstract

The present invention relates to the fields of biotechnology and molecular biology. In particular, the present invention relates to the construction and use of nucleic acid molecules comprising cloning sites which differ in nucleotide sequence. In particular embodiments, the present invention relates to nucleic acid molecules which contain recombination sites with different primer binding sites. These different primer binding sites may be used to sequence different ends of nucleic acid segments located between the two recombination sites.

Claims

1. A method for sequencing all or part of a nucleic acid segment, the method comprising;

(a) performing a topoisomerase cloning reaction comprising;

(i) providing the nucleic acid segment which comprises a 3′

overhang at each end;

(ii) providing a second nucleic acid molecule having a 5′

overhang at each end complementary to the 3′

ends and a covalently linked topoisomerase at each of the 5′

ends and wherein the second nucleic acid molecule also comprises at each of the 5′

ends a first attL site and a second attL site which do not recombine with each other and wherein the first and the second attL sites each have a sequencing primer binding site wherein the sequencing primer binding sites encompass the IHF site of the first and the second attL sites and wherein the sequencing primer binding sites differ from each other by one, two, three or four nucleotides;

(iii) combining the nucleic acid segment with the second nucleic acid molecule such that the 3′

overhang of the nucleic acid segment hybridizes with the 5′

overhang of the second nucleic acid molecule and the covalently linked topoisomerase ligates the nucleic acid segment and the second nucleic acid molecule resulting in the generation of a product nucleic acid molecule comprising the second nucleic acid molecule and the nucleic acid segment and allow for sequencing of the nucleic acid segment from the first and the second attL sites;

(b) contacting a first set of the product nucleic acid molecule of (a) with a first sequencing primer which hybridizes to both of the primer binding sites of the product nucleic acid molecule, wherein the first sequencing primer mediates 5′

to 3′

extension from only one of the two binding sites and sequencing all or part of the nucleic acid segment with the first sequencing primer.

2. The method of claim 1, further comprising the steps of:

(c) contacting a second set of the product nucleic acid molecule of (a) with a second sequencing primer which hybridizes to both of the primer binding sites of the product nucleic acid molecule, wherein the second sequencing primer mediates 5′

to 3′

extension only from the primer binding site at the opposite end of the nucleic acid segment from the primer binding site bound by the first sequencing primer and sequencing all or part of the nucleic acid segment with the second sequencing primer.

3. The method of claim 2, wherein the first sequencing primer and the second sequencing primer are each between 15 and 45 nucleotides in length.

4. The method of claim 3, wherein the difference in nucleotide sequence of the first sequencing primer and the second sequencing primer is at the 3′

termini therein.

5. The method of claim 4, wherein the first sequencing primer comprises the nucleotide sequence 5′

GTTGCAACAAATTGATGAGCAATTA 3′

(SEQ ID NO.

     1) and the second sequencing primer comprises the nucleotide sequence 5′

GTTGCAACAAATTGATGAGCAATGC 3′

(SEQ ID NO.

     2).